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Digitalization: “The encoding of analogue information into a digital format and the possible 
subsequent reconfigurations of the socio-technical context of production and consumption of the 
associated products and services”.[1] 
 
This edition includes two papers reporting research from a five year study of electronic 
prescribing in English hospitals.[2 3]  These papers each address a significant safety and 
quality issue drawing data from the wider study. These issues are  the level of coordination 
and integration that electronic prescribing systems achieve,[3] and the emergence of 
‘workarounds’ as managers and clinical users adapt electronic prescribing systems’ 
capabilities to their needs and working environment.[2] . The risks to patient safety posed 
by these systems, their implementation and use, are further explored in a third associated 
paper published elsewhere.[4]  
 
Workarounds were found to be either ‘informal’ or ‘formalised’ practices, the former 
derived from user innovations, the latter promoted and endorsed by management. Both 
types involved the use of other ‘intermediary systems’, such as paper or other software.[2] 
While workarounds can create new risks and are an opportunity for safety issues to 
emerge, the study does acknowledge the positive role of workarounds in permitting poor 
usability of systems to be addressed, as ‘intentional strategies to help users gradually get 
used to a new system’, and as a means to support local innovation and tailoring.  
 The issue of integration of information is a common theme that crosses both studies.  
Workarounds, arguably, serve to better integrate information into work practices while the 
interfacing of multiple digital systems can provide a more coherent and timely flow of 
information. The research reports that even integrated hospital-wide systems were found 
not to interface well with external systems.[3]  It is important to note that the systems 
considered for integration with electronic prescribing in these studies are not necessarily 
medicines’ systems (e.g. in pharmacy) – they include also administration, imaging, 
laboratory, or specialty systems and the systems are not differentiated in terms of the data 
they hold – whether about medicines, or patients, or other operational data.  
 
For the organisation, the choice between the integration provided by integrated  hospital-
wide EHR packages or interfacing (‘knitting together’ different standalone software – 
sometimes described as a ‘best of breed approach’) was found to pose a complex set of 
trade offs among  a ‘range of considerations, of which patients safety is only one’. [3]   
 
These studies provide valuable and detailed accounts of the state of the art in electronic 
prescribing in England. They also offer an opportunity to reconsider how we conceptualise 
the role of digital technology in improving the way medicines are used. To do so, we 
identify three interlinked contemporary themes to add to or recast those emerging from 
these papers and described above. The three additional themes are: (1) considering the 
medicine itself as a ‘digital artefact’; (2) the significance of time in medicines use; and (3) 
the architectures of the digital systems supporting medicines use. Taken together these 
may invite a change in scope and focus of the discussion of electronic prescribing – to 
move from task orientation (prescribing, administration, discharge) to an institution-wide or 
even system-wide perspective that emphasise data and communications infrastructures in 
support of new services and processes specifically for ‘digital medicines’.  
Medicines as digital artefacts  
 
Digital Artefacts: Editable, interactive, reprogrammable, and distributable resources. 
Their value and utility is contingent on shifting webs of functional relations with other 
artefacts across contexts and organizations.[5] 
 
When considering the implementation and use of digital systems such as electronic 
prescribing, it is easy to focus on the task at hand and forget the physical artefacts these 
systems represent and combine with - in this case, medicines.  Medicines are products 
with multiple physical and digital realizations and representations, representations that are 
potentially editable, interactive, reprogrammable and distributable. Thus any given 
medicine will exist in many different databases, including manufacturing and supply chain, 
research and clinical trials, regulation and licensing, institutional stock handling, protocols 
and guidelines, electronic prescribing, dispensing and administration, as well as in patient 
records and other registries. However, the digital artefact, as a summation of such 
representations, has not so far shaped  how we have thought to date about electronic 
prescribing and other medicines related systems. Each partial digital representation has 
been taken more or less as separate and relating to a particular task, place and time.  
 
More focus on the medicine as a data rich digital artefact may lead to increased 
awareness that medicines are different one from another in many dimensions, including 
their storage, transport, legal and regulatory status, protocols of use, and in the ways that 
they ‘match’ the patient’s needs. Recognition of this may yield new capabilities for safer 
use of medicines. The logic of the current generation of electronic prescribing systems, as 
studied in the papers considered here, is that all medicines can be accommodated within 
the constraints of limited pre-set functionality and on the basis of a given database. Thus, 
a primary motivation for ‘workarounds’, as suggested by Cresswell et al [2] is the 
recognition that a particular medicine does not ‘fit’ the system’s assumptions.  
Medicines in time and space 
 
Medicines are artefacts with a complex time dimension. Safe use of medicines is 
fundamentally related to their being made available at the right time and right place. 
Thinking of medicines as digital artefacts can offer powerful means to control time and 
place – to position medicines at the time and place when they are needed (e.g. in the 
warehouse, in the automated dispensing machine, on the drug round, ready for patient 
discharge), and to monitor the timeliness of activities (e.g. dispensing, transport, 
administration). This can serve in process improvements and potentially cash saving 
efficiencies, including in the management of logistics and supply chains [6]. The ability to 
better account for temporality of the artefact may also lead to the design and 
implementation of better software with interfaces and decision support that confidently 
draws on temporal data. Of course, such capabilities will also offer new potential to create 
errors of time and place – to mis-locate medicines or to mis-specify time controls. 
 
Time and place dimensions are also apparent in electronic prescribing systems 
implementation and support processes, as evident from the studies considered here. 
System roll-out  and user adoption takes time; it takes place in time and across locations 
as work processes adapt and change (including workarounds); implementation should not 
be conceived as a one-off task, but as an adjusting and evolving process over time, that is 
directed in part by data on medicines accumulated during system use. Thus the medicine 
as a digital artefact can ‘know’ its own history and use this data to help innovate 
behaviours. 
Architectures and infrastructures 
 
Cresswell et al [3] suggest that to achieve even minimal integration of electronic 
prescribing with other hospital systems, the hospitals they studied faced a bald choice 
between adopting a single integrated bundle of inflexible software and functionality, or 
taking on the task of interfacing their chosen electronic prescribing software with other 
systems. Future generations of electronic prescribing software may need a new 
architecture to help institution’s get beyond this dilemma. Achieving the safety and 
efficiency benefits from viewing medicines as digital artefacts will require common, shared, 
networked, services in support of integrated working – a digital medicines infrastructure. 
How might we get there?  
 
We know from recent research that the way digital infrastructures emerge and develop is 
different from how our current generation of electronic prescribing systems and electronic 
patient records have been developed.  The packaged software and commercial off-the-
shelf solutions used for electronic prescribing today are for the most part based on 
proprietary code and limited, task-focused, requirements analysis. Digital infrastructures, in 
contrast, evolve as they respond to and meet multiple needs.[5] The resulting architecture 
focuses on providing shared services, and their cultivation and evolution (see Box 1).   
 
Box 1. Six core concepts of digital infrastructure, adapted from [5] 
1. Shared: a digital infrastructure is shared by the members of a community. 
2. Evolving: a digital infrastructure is not designed or created in a singe act, but 
evolves continually as it expands in scale and is adapted for new purposes. 
3. Open: a digital infrastructure is available for new users and new uses.  
4. Standardized: a digital infrastructure needs agreed common standards to ensure 
its functional integrity and allow it to scale up. 
5. Heterogeneous: a digital infrastructure consists of different elements: technology, 
users, organizations, governance.  
6. Installed base: a digital infrastructure will build on, expand and integrate previous 
systems and services. 
 
 
We are today in the earliest phases of developing the standards and resources that open 
up the option of a digital medicines infrastructure at the hospital scale and upon which 
multiple services might be built. Why, for example, should a hospital not be able to deploy 
services that allow a prescriber to look at the stock of a medicine, its price, its use for other 
patients/patient groups, current research and so on. Such a case looks beyond separate 
software driven islands for procurement, prescribing, dispensing, administration, 
discharge, research, audit and so on, and moves towards a core digital artefact, served by 
a new infrastructure that allows multiple task-oriented software applications to support safe 
and context relevant work practices reflecting a rich detail of specific medicines.  
 
At one level such an infrastructure is just a step or two on from the ‘interfacing’ model that 
Cresswell et al. introduce.[3] However, infrastructures have another essential and valuable 
quality – that of generativity, “a system’s capacity to produce unanticipated change 
through unfiltered contributions from broad and varied audiences.”[7] 
 
In providing services that support the flexible and open sharing and mixing of digital 
artefacts (medicines but also patients, samples, tests, population data, demand data, etc.) 
the opportunity for ‘contributions’ from the broader community is reinvigorated. Today, as 
Cresswell et al. note [2], the users of electronic prescribing software have few 
opportunities to take their own ideas and make them work. By separating the infrastructure 
layer, where digital artefacts and associated services are made available to share, from 
the users’ applications layer , this engine of innovation – including innovation in safety -  
may be restarted.  
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